Evogliptin | m-entrepreneurship.com

Product Name :
Evogliptin

Search keywords :
Evogliptin

drugId :
null

Target Vo:
Dipeptidyl peptidase IV

Target Vo Short Name :
DPP4

Moa_Name:
Dipeptidyl peptidase IV inhibitors

First Approval Country :
South Korea

First Approval Date Filter:
2015

Origin Company_Name :
Dong-A Pharmaceutical Co Ltd

Active Company_Name :
Dong-A Pharmaceutical Co Ltd

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:
Liver Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
N Cadherin Antibody
MMAE Antibody (YA899)
ICAM1 Antibody (YA725): ICAM1 Antibody (YA725) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to ICAM1. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts